학술논문
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.
Document Type
journal article
Author
Antonarakis, Emmanuel S.; Tagawa, Scott T.; Galletti, Giuseppe; Worroll, Daniel; Ballman, Karla; Vanhuyse, Marie; Sonpavde, Guru; North, Scott; Albany, Costantine; Che-Kai Tsao; Stewart, John; Zaher, Atef; Szatrowski, Ted; Wei Zhou; Gjyrezi, Ada; Shinsuke Tasaki; Portella, Luigi; Yang Bai; Lannin, Timothy B.; Shalu Suri
Source
Journal of Clinical Oncology; 10/1/2017, Vol. 35 Issue 28, p3181-3188, 11p
Subject
Language
ISSN
0732183X